₹12.97 Crores | Listing at BSE | Mon, Feb 26, 2024 - Wed, Mar 20, 2024
Dipna Pharmachem Ltd. Rights Issue comprises 1.30 Cr equity shares aggregating to ₹12.97 Cr, offered at an issue price of ₹10 per share with a face value of ₹10 per share.
The record date for determining eligible shareholder is Feb 12, 2024, with the Rights Issue being offered in the entitlement ratio of 13 : 12.
The term of payment is defined as following : Full amount of Rs. 10/- per Equity share is payable on application by Eligible Equity shareholders.
The Rights Entitlements are expected to be credited to eligible demat accounts on Mar 14, 2024.
The Rights Issue opens on Feb 26, 2024, and closes on Mar 20, 2024, with renunciation of Rights Entitlements permitted up to Mar 4, 2024.
The deemed date of allotment is Mar 14, 2024, following which the equity shares are expected to be credited to demat accounts on Mar 15, 2024 and listed at the BSE on Mar 18, 2024.
Bigshare Services Pvt.Ltd. is the Registrar to the Issue.
Investors are advised to refer to the Dipna Pharmachem Ltd. Letter of Offer for detailed information, including risk factors, issue terms, and procedural details.
Record Date
Mon, Feb 12, 2024
Entitlement Ratio
13 : 12
Open Date
Mon, Feb 26, 2024
Close Date
Wed, Mar 20, 2024
Full amount of Rs. 10/- per Equity share is payable on application by Eligible Equity shareholders.
Dipna Pharmachem Ltd.'s revenue increased by 37.34% and profit after tax (PAT) dropped by -21.85% between the financial year ending with March 31, 2023 and March 31, 2022.
| Period Ended | 31 Mar 2023 | 31 Mar 2022 |
| Assets | 77.56 | 36.23 |
| Revenue | 99.93 | 72.77 |
| Profit After Tax | 0.91 | 1.17 |
| Reserves and Surplus | 12.39 | 1.70 |
| Amount in ₹ Crore | ||
Incorporated in 2011, Dipna Pharmachem Limited (DPL) is an India-based company that trades, imports, and exports industrial chemical and pharmaceutical raw materials.These include active pharmaceutical ingredients (APIs), excipients, and chemical formulation products.
The company exports its products globally. Dipna Pharmachem Limited offers import and export services to customers worldwide.
The company has a wide range of offerings, including expertise in marketing and sourcing of industrial chemicals, pharmaceutical raw materials, APIs, solvents, and formulation and intermediates. They also provide assistance in setting up contract manufacturing compliance for regulated and semi-regulated pharmaceutical companies, ensuring that all global benchmark parameters are met and leading certificates like WHO-GMP are obtained.
The company intends to utilize the net proceeds from the issue towards the funding of the following objects:
[Dilip Davda] Though this RI is at par, its inconsistent performance and third party dependence for its trading activities are the major concerns. Well-informed/cash surplus investors may park moderate funds for the medium term. Read detail review...
Dipna Pharmachem Rights Issue 2024 got oversubscribed by 1.03 times by the end of the bidding period with total bid quantity received by BSE of 1,33,51,000 shares. Check Day by Day Subscription Details (Live Status)
| Date | BSE Bid Quantity | Subscription Times |
|---|---|---|
Mar 20 2024 17:00:00 | 1,33,51,000 | 1.03x |
Dipna Pharmachem Ltd.
A/211, Siddhi Vinayak Complex,
Near D.A.V. School
Makarba, Ahmedabad – 380 055
Ahmedabad, Gujarat, 380055
The Dipna Pharmachem Rights Issue 2024 opens on Mon, Feb 26, 2024, and closes on Wed, Mar 20, 2024.
Dipna Pharmachem Rights Issue 2024 Schedule
| Last Date for credit of Rights Entitlements | Mon, Feb 19, 2024 |
| Last Date for renunciation of Rights Entitlements | Mon, Mar 4, 2024 |
| Issue Opening Date | Mon, Feb 26, 2024 |
| Issue Closing Date | Wed, Mar 20, 2024 |
| Date of Allotment (on or about) | Thu, Mar 14, 2024 |
| Date of Credit (on or about) | Fri, Mar 15, 2024 |
| Date of Listing (on or about) | Mon, Mar 18, 2024 |
You can apply for Dipna Pharmachem Rights Issue 2024 in two ways:
Steps to apply for Dipna Pharmachem Rights Issue 2024 using Net Banking (ASBA)
Steps to apply for Dipna Pharmachem Rights Issue 2024 using Registrar's website (R-WAP)
